UPC APP 16366/2025
EP4183412 Unitary patent · RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
- Case details
- StatusWithdrawnActionProcedural applicationCategoryWithdrawal applications
- Parties
- Claimants
- Pfizer Inc.Operating co.
- Pfizer Europe MA EEIGOperating co.
- Pfizer B.V.Operating co.
- Pfizer S.A.Operating co.
- Pfizer Manufacturing Belgium NVOperating co.
- Pfizer Service Company S.R.L.Operating co.
- Pfizer Pharma GmbHOperating co.
- Pfizer LimitedOperating co.
- Pfizer Corporation Austria GmbHOperating co.
- Pfizer ApSOperating co.
- Pfizer OyOperating co.
- Pfizer SASOperating co.
- Pfizer S.r.l.Operating co.
- Laboratórios Pfizer, Lda.Operating co.
- Pfizer ABOperating co.
- Pfizer Luxembourg SARLOperating co.
Representatives- Gareth Williams-Marks & Clerk LLP
Respondents- GlaxoSmithKline Biologicals SAOperating co.
Representatives- Oliver Jan Juengst-Bird & Bird LLP
- Daniela Kinkeldey-Bird & Bird LLP
- Division
- Milan CD
- Technology
- ChemistryBiotechnology · Pharmaceuticals
- Language
- —
- First decided
- Apr 22, 2025
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Milan CD | Locked |
| Judge Andrea Postiglione | Locked |
| Judge Anna-Lena Klein | Locked |
| Judge Steen Wadskov-Hansen | Locked |
At the UPC: Pfizer Group (31 cases)·GlaxoSmithKline Biologicals SA (20 cases)
This dispute contains 8 other proceedings
UPC CFI 687/2024·UPC CFI 476/2024·UPC CFI 468/2024·UPC APP 16306/2025·UPC APP 17607/2025 and 3 more
- 2025-04-22Application RoP 265Public
Summary: Milan Central Division procedural order granting Pfizer's application to withdraw a revocation action against GlaxoSmithKline Biologicals SA concerning EP 4 183 412 (RSV F protein vaccine patent), and a separately filed counterclaim for revocation in parallel Düsseldorf infringement proceedings (which had been referred to the Central Division). Pfizer and Glaxo had each filed applications to amend the patent; both revocation actions were withdrawn by Pfizer prior to closure of the written procedure. The court also ordered 60% reimbursement of court fees and confirmed each party bears its own costs.
Show the legal issues (4)
- Withdrawal of revocation action (R. 265.1 RoP)
- Reimbursement of court fees (R. 370 RoP)
- Referral of counterclaim for revocation from local to central division
- Application to amend patent
- 83A40873F1721B10D2423F4CB5182319_en.pdf2025-04-22EN